Article
Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening.
Virology journal - 20 Mar 2018
Iacobellis Michela, Violante Cecilia, Notarachille Gabriella, Simone Angela, Scarfì Rosa, Giuffrè Giuseppe
Abstract excerpt
BACKGROUND: According to international guidelines, HPV DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more severe lesions. The aim of this study was to assess whether REALQUALITY RQ-HPV Screen, a new assay based on real time PCR that targets the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
